In Alzheimer’s disease, the inhibition of mTOR by rapamycin ameliorates the synthesis of β-amyloid and tau protein and improves learning and memory abilities (Spilman et al., 2010). The gene discussed is MTOR; the disease is early-onset autosomal dominant Alzheimer disease.